Results 1 to 10 of about 106,964 (161)

Appropriateness of Percutaneous Coronary Intervention [PDF]

JAMA - Journal of the American Medical Association, 2011
Despite the widespread use of percutaneous coronary intervention (PCI), the appropriateness of these procedures in contemporary practice is unknown.To assess the appropriateness of PCI in the United States.Multicenter, prospective study of patients within the National Cardiovascular Data Registry undergoing PCI between July 1, 2009, and September 30 ...
Manesh Patel, , Frederick Masoudi
exaly   +3 more sources

Clopidogrel and Percutaneous Coronary Interventions

JAMA: The Journal of the American Medical Association, 2003
case fatality rates in inhaled anthrax can approach 100%. Anthrax bacteria, after being inhaled, use three toxins— protective antigen, oedema factor, and lethal factor—to enter, appropriate, and kill alveolar macrophages. Seven copies of protective antigen assemble and facilitate entry of oedema factor and lethal factor into macrophages.
Brian Y L, Wong, Eric A, Cohen
  +11 more sources

Fractional flow reserve in assessment of intermediate non-culprit lesions in acute myocardial infarction [PDF]

Journal of Pharmacy & Pharmacognosy Research, 2023
Context: Percutaneous coronary intervention (PCI) of intermediate non-culprit arteries can reduce death or heart attack risk in patients with acute myocardial infarction and multivessel coronary artery disease.
Do Truong Son Chau, Quang Binh Truong, Do Anh Nguyen, Manh Thong Le, Dinh Dat Nguyen, Anh Tien Hoang   +5 more
doaj   +1 more source

Guidelines for Percutaneous Coronary Interventions [PDF]

European Heart Journal, 2005
In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with only one exception: chronic total occlusions that cannot be crossed. In early studies, there was a small survival advantage with CABG surgery compared with PCI
Silber, Sigmund, Albertsson, Per, Avilés, Francisco F., Camici, Paolo G., Colombo, Antonio, Hamm, Christian, Jørgensen, Erik, Marco, Jean, Nordrehaug, Jan-Erik, Ruzyllo, Witold, Urban, Philip, Stone, Gregg W., Wijns, William, Deckers, Jaap, Bassand, Jean-Pierre, Battler, Alexander, Bertrand, Michel, Betriu, Amadeo Gibert, Cokkinos, Dennis, Danchin, Nicolas, Di Mario, Carlo, de Feyter, Pim, Fox, Kim, Indolfi, Ciro, Karsch, Karl, Steg, Philippe Gabriel, Tendera, Michal, Van de Werf, Frans, Verheugt, Freek W. A., Widimski, Petr   +29 more
openaire   +3 more sources

Advancement in Coronary Angiography or Percutaneous Coronary Intervention Using the Distal Transradial Artery Access in Acute Coronary Syndrome and Complex Coronary Artery Disease

Anatolian Journal of Cardiology, 2022
As the incidence of coronary heart disease increases annually, coronary angiography and percutaneous coronary intervention procedures are also increasing. The femoral artery and radial artery paths are commonly used for percutaneous coronary intervention,
Gang Cao, Hua-xiu Cai, Jun Cao
doaj   +1 more source

Percutaneous Coronary Interventions in Women

Current Atherosclerosis Reports, 2023
Abstract Purposeof Review Cardiovascular disease is the leading cause of morbidity and mortality among women globally. Numerous studies show ongoing disparities in diagnosis, management, and outcomes of ischemic heart disease in women compared to men.
Joodi, Golsa, Palimar, Sristi, Press, Marcella Calfon   +2 more
openaire   +2 more sources

Transient lateral rectus palsy associated with acute coronary syndrome treated with percutaneous coronary intervention: a case report

Journal of Medical Case Reports, 2023
Background Patients who experience angina and acute myocardial infarction often receive diagnostic coronary angiography and percutaneous coronary intervention.
Ali Asghar Farsavian, Mahya Mobinikhaledi, Parastoo Ghorbani, Erfan Ghadirzadeh   +3 more
doaj   +1 more source

Comparing results of bypass surgery and percutaneous coronary intervention for left main disease by surgical revascularization pump strategyCentral MessagePerspective

JTCVS Open, 2023
Objective: We performed a post hoc analysis of the Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial to determine the effect an on-versus off-pump strategy had on outcomes when ...
Craig M. Jarrett, MD, MBA, Marc Pelletier, MD, Yasir Abu-Omar, MD, Cristian Baeza, MD, Yakov Elgudin, MD, PhD, Alan Markowitz, MD, Zhipeng Zhou, MA, Björn Redfors, MD, PhD, Ovidiu Dressler, MD, Arie Pieter Kappetein, MD, PhD, Patrick W. Serruys, MD, PhD, Gregg W. Stone, MD, Joseph F. Sabik, III, MD   +12 more
doaj   +1 more source

Bivalirudin in percutaneous coronary intervention [PDF]

Vascular Health and Risk Management, 2006
Bivalirudin is a member of the direct thrombin inhibitor group of anticoagulants. It has been evaluated as an alternative to unfractionated and low-molecular-weight heparins in the settings of percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS). Results of clinical trials to date suggest bivalirudin is a viable alternative to the
Lehman, Sam, Chew, Derek Peng
openaire   +3 more sources

Drug-eluting balloon: is it useful?

The Egyptian Heart Journal, 2020
Background Coronary artery disease is one of the major issues in the medical world around the globe. The prevalence tends to increase. The use of coronary intervention is one of the ways often used in the management of coronary artery disease due to its ...
Sidhi Laksono, Budhi Setianto, Steven Philip Surya   +2 more
doaj   +1 more source